Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14
Open Access
- 15 March 1993
- Vol. 71 (6), 2082-2096
- https://doi.org/10.1002/1097-0142(19930315)71:6<2082::aid-cncr2820710625>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- SPECT Anti-CEA Monoclonal Antibody Detection of Occult Colorectal Carcinoma MetastasesClinical Nuclear Medicine, 1991
- Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.Journal of Clinical Oncology, 1991
- Selection of a dtpa chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude miceInternational Journal of Cancer, 1990
- Imaging of colorectal carcinoma with radiolabeled antibodiesSeminars in Nuclear Medicine, 1989
- Cea-related antigens: Molecular biology and clinical significanceCritical Reviews in Oncology/Hematology, 1985
- Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kDInternational Journal of Cancer, 1984
- Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigenMolecular Immunology, 1982
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978
- Identification of an Antigen from Normal Human Tissue That Crossreacts with the Carcinoembryonic AntigenProceedings of the National Academy of Sciences, 1972
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965